🔥 TRENDING One dead as fire engulfs Lajpat Nagar... Aishwarya Rai Stuns in Cannes 2026 Gow... Air India’s Vista Platform Wins ‘Seaml... MAMA Awards 2026: Broadcast dates and... Five Teens Charged with Murder in Aust... Activist Archivists Revive Vintage Hom...
20 Nov 2026•
ગુજરાતી मराठी ਪੰਜਾਬੀ বাংলা
Kerala CPI-M Faces Backlash Over SMA Drug Controversy
📷 Image: Wikimedia Commons / Sivahari
Politics

Kerala CPI-M Faces Backlash Over SMA Drug Controversy

✍️ Tripuratimes 🗓 25 Oct 2026, 07:46 AM 👁 80
Share: 💬 WhatsApp 📘 Facebook 𝕏 Post

The CPI-M in Kerala is facing criticism over a controversy surrounding the availability of a life-saving drug for children with Spinal Muscular Atrophy (SMA).

The Communist Party of India (Marxist), or CPI-M, which governs Kerala, is under fire for its handling of the SMA drug situation. Families of children with SMA have alleged that the government has not made the necessary arrangements to ensure the timely availability of the expensive drug, Zolgensma. This has led to protests and accusations of negligence against the CPI-M administration. The controversy has highlighted the challenges faced by patients and families in accessing essential medications in Kerala.
📲Get App